FOR RESPONSE TO INQUIRIES
Monday, September 14, 1998
NCI Press Office
NSABP Operation Center
Breast Cancer Prevention Trial Results Published
- Number of first-degree relatives (mother, daughters, or sisters) who
had been diagnosed as having breast cancer;
- Whether a woman had any children and her age at her first delivery;
- The number of times a woman had breast lumps biopsied, especially if
the tissue was shown to have a condition known as atypical hyperplasia;
- The woman's age at her first menstrual period; and
- Whether a woman has had a type of noninvasive breast cancer known as
lobular carcinoma in situ.
A computer-based tool that allows health professionals to project a woman's
individualized estimate of breast cancer risk is being released in a pilot
program by NCI this month. The Breast Cancer Risk Assessment Tool is a computer
program that women and their health care providers can use to estimate a
woman's chances of developing breast cancer based on several established
risk factors. Researchers from NCI and NSABP developed the tool. The disk
is available at no charge and in personal computer (PC) and MacIntosh computer
formats. To order, call the NCI's Cancer Information Service at 1-800-4-CANCER
or visit NCI's CancerTrials Web site at http://cancertrials.nci.nih.gov.
* The study is titled, "Tamoxifen for Prevention of
Breast Cancer: Report of the National Surgical Adjuvant Breast and Bowel
Project P-1 Study. The authors are B. Fisher, J.P. Costantino, D.L. Wickerham,
C.K. Redmond, M. Kavanah, W.M. Cronin, V. Vogel, A. Robidoux, N. Dimitrov,
J. Atkins, M. Daly, S. Wieand, E. Tan-Chiu, L. Ford, N. Wolmark, and other
NSABP investigators. Journal of the National Cancer Institute, Vol. 90,
Sept. 16, 1998.
Other Sources of Information
Questions and Answers are
also available on the NCI Website or from the NCI Press Office.
For information on the Breast Cancer Prevention Trial and easy access
to all clinical trials information from the National Cancer Institute, go
For information on National Surgical Adjuvant Breast and Bowel Project
clinical trials, including future prevention trials, go to http://www.nsabp.pitt.edu.